Connection
Jeffrey Glasheen to Warfarin
This is a "connection" page, showing publications Jeffrey Glasheen has written about Warfarin.
|
|
Connection Strength |
|
 |
|
 |
|
1.291 |
|
|
|
-
Glasheen JJ, Prochazka AV. Further evidence of a clinically significant levofloxacin-warfarin interaction. South Med J. 2008 Jun; 101(6):660; author reply 660.
Score: 0.284
-
Glasheen JJ, Prochazka AV. The safety of levofloxacin in patients on warfarin. Am J Med. 2007 Apr; 120(4):e13; author reply e15-6.
Score: 0.262
-
Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med. 2005 Jul; 20(7):653-6.
Score: 0.232
-
Glasheen JJ. Preventing warfarin-related bleeding. South Med J. 2005 Jan; 98(1):96-103.
Score: 0.224
-
Glasheen JJ, Fugit RV, Prochazka AV. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment. Pharmacotherapy. 2003 Aug; 23(8):1079-80; discussion 1080.
Score: 0.203
-
Levin D, Smith DB, Cumbler E, Carter J, Glasheen JJ, Jones W. Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis. Arch Neurol. 2011 Jan; 68(1):135; author reply 135-6.
Score: 0.085